Nihon Kohden Corporation
Stock Price Chart
2026/10/09 12:26 UpdatedPrice Trend
2026/10/09 12:26 UpdatedPrice & Trading Details
2026/10/09 12:26 UpdatedPRICE
TRADING
Analyst Recommendations 8 analysts
Updated 2026/10/01Earnings Calendar
Updated 2026/10/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026/08/05 | ¥1.88 | ¥-4.73 | -352.2% |
| 2026/05/14 | ¥33.97 | ¥49.94 | +47.0% |
| 2026/02/04 | ¥12.99 | ¥11.57 | -10.9% |
| 2025/11/10 | ¥23.30 | ¥26.90 | +15.4% |
Shareholder Composition
Updated 2026/10/01Top Mutual Funds / ETFs
Updated 2026/10/01Major Holders
Updated 2026/10/01| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
First Eagle Funds-First Eagle Overseas Fund
|
6.8M | 0.00% | |
|
VANGUARD TRUSTEES' EQUITY FUND-Vanguard International Value Fund
|
3.1M | 0.00% | |
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
2.3M | 0.00% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
1.5M | -1.72% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
1.2M | +0.28% | |
|
-First Eagle Overseas Equity ETF
|
644.3K | +52.61% |
Dividend History
Updated 2026/10/04| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥32 | 0.0% |
| 2025 | ¥32 | +4.9% |
| 2024 | ¥31 | -14.1% |
| 2023 | ¥36 | +4.4% |
| 2022 | ¥34 | - |
Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥205,129M | ¥206,603M | ¥221,986M | ¥225,424M |
| Gross Profit | ¥109,085M | ¥105,926M | ¥111,346M | ¥117,157M |
| Operating Income | ¥30,992M | ¥21,121M | ¥19,591M | ¥20,713M |
| Pretax Income | ¥34,274M | ¥24,726M | ¥29,393M | ¥21,714M |
| Net Income | ¥23,435M | ¥17,110M | ¥17,026M | ¥14,098M |
| EPS | ¥138.25 | ¥101.64 | ¥101.22 | - |
| Operating Margin | 15.11% | 10.22% | 8.83% | 9.19% |
| Balance Sheet | ||||
| Total Assets | ¥210,201M | ¥216,728M | ¥233,233M | ¥258,276M |
| Total Equity | ¥156,378M | ¥167,602M | ¥181,080M | ¥179,550M |
| Total Liabilities | ¥53,823M | ¥49,126M | ¥52,153M | ¥78,726M |
| Cash | ¥28,925M | ¥33,459M | ¥36,132M | ¥28,428M |
| Interest-bearing Debt | ¥359M | ¥441M | ¥654M | ¥26,076M |
| Equity Ratio | 74.39% | 77.33% | 77.64% | 69.52% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.15 |
| Cash Flow | ||||
| Operating CF | ¥25,699M | -¥2,513M | ¥15,607M | ¥15,286M |
| Investing CF | -¥4,303M | -¥7,647M | -¥5,208M | -¥25,138M |
| Financing CF | -¥7,300M | -¥7,485M | -¥6,968M | ¥2,550M |
| Free CF | ¥22,765M | -¥10,769M | ¥10,821M | ¥6,577M |
| Efficiency | ||||
| ROE | 14.99% | 10.21% | 9.40% | 7.85% |
| ROA | 11.15% | 7.89% | 7.30% | 5.46% |
Latest IR Information
-
Notice regarding share acquisitions as defined by government ordinance as acts equivalent to tender offers
Acquisition of 10,414,800 shares of Nihon Koden Kogyo Co., Ltd. (6.48% of total voting rights) through a fund management company. Acquisition date: 2026/09/10. The purchase falls under a purchase equivalent to a tender offer.
Read more -
August 6, 2026 Nihon Kouden Kōgyō Kabushiki Kaisha Q1 2026 Earnings Presentation
Q1 shows changes in sales versus the prior period and year, with domestic and international segment contributions implied. Full-year guidance is presented in the separate document, and factors influencing future performance are organized.
Read more -
Q1 Fiscal Year Ending March 2027 Financial Summary (Japanese GAAP)
Disclosure of the consolidated financial results and financial position for the first quarter of the fiscal year ending March 2027. Reports trends in revenue and profit, segment-by-segment status, and key financial indicators. As a quarterly financial summary, includes year-ago comparatives...
Read more -
Notice Regarding the Disposal of Treasury Stock as Restricted Stock
Disposal of treasury stock as restricted stock compensation. Targets are 4 directors and 15 corporate officers, 60,195 shares, price 1,500 yen per share, total 9,029,2500 yen. Grants are dated July 31, 2026, with the grant period until retirement, and detailed...
Read more
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥1,788
Rating Score: 2.50 (Based on 8 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Nihon Kohden Corporation engages in research and development, production, sales, and repair and maintenance of medical electronic equipment in Japan, North America, Latin America, Europe, Asia, and internationally. It offers physiological measuring equipment, such as electroencephalographs, evoked potential and electromyogram measuring systems, electrocardiographs, polygraphs for Cath lab, diagnostic information systems, recording paper, electrodes, and EP catheters. The company also provides patient monitors, including central monitors, bedside monitors, wireless monitors, remote access software and other equipment, clinical information systems, and electrodes and sensors. In addition, it offers defibrillators, automated external defibrillators(AED), ventilators, pacemakers, anesthesia machines, automated chest compression devices, AED pads, batteries, and ablation catheters; hematology analyzers, clinical chemistry analyzers, ultrasound diagnostic equipment and others, consumables, including test reagents, and installation and maintenance services. Further, it is involved in technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.
